News | November 03, 2009

PETNET to Supply ACRIN Multicenter Trial Network

18F-NaF PET image

November 2, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions, announced it is a registered supplier of 18F-sodium fluoride  (18F-NaF) and investigational 3’Deoxy-3’[18F] Fluorothymidine (18F-FLT)  to the American College of Radiology Imaging Network (ACRIN) in support of ACRIN’s multi-center clinical trials.
Availability of 18F-NaF and 18F-FLT will be made via a cross reference from Siemens’ Drug Master Files (DMF) to the National Cancer Institutes (NCI) centralized IND’s, under which the ACRIN trial will be performed.  The cross reference allows both products to be produced and used by any principle investigator in an ACRIN clinical trial. In addition, the imaging biomarkers will be available to investigators outside of ACRIN trials if they receive independent FDA approval of an IND or appropriate authorization, such as a local Radioactive Drug Research Committee (RDRC) approval or Institutional Review Board (IRB) approval.
18F-FLT has been used in studies to monitor the proliferative activity of cancer cells.  18F-sodium fluoride (18F-NaF) is an FDA-approved imaging agent and will be studied in the detection of bony metastases. Clinical trial support of both imaging agents provides the medical community with better access to 18F-FLT and 18F-NaF by leveraging Siemens biomarker technology and PETNET Solutions as the industry’s largest network of PET biomarker production facilities.
For more information:

Related Content

United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
BGN Technologies Introduces Novel Medical Imaging Radioisotope Production Method
News | Radiopharmaceuticals and Tracers | June 05, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...